EnBW New Ventures has come on board as a new investor to help superconductor producer Theva close its second funding round in the space of a year.

Vinci Energies is one of several limited partners to contribute to a $28.5m first close for enterprise technology acceleration platform Axeleo's first fund.

The Manchester spinout is seeking capital to launch its first product, a test that can detect the early-stage onset of an eye disease called age-related macular degeneration.

Existing investor Novo Ventures contributed to a series C round announced alongside Unchained Labs' acquisition of protein measurement device maker Trinean.

Frontier IP has received a 20% stake in Molendotech, a new spinout of Plymouth University that has developed a way to test the purity of water.

The pharmaceutical company has bought diabetes management platform MySugr for an undisclosed sum, two years after its corporate venturing unit backed a $4.8m seed round.

The Federal Ministry of Education and Research has allocated capital to institutions such as University of Potsdam to bolster technology transfer activities.

The company has licensed the platform of University College London spinout Nanogenics to develop a cancer treatment.